cetrimide

Small moleculeexperimental

Cetrimide, or alkyltrimethylammonium bromide, is an antiseptic which is a mixture of three quaternary ammonium compounds: tetradonium bromide, cetrimonium bromide (CTAB), and laurtrimonium bromide. It was first discovered and developed by ICI and introduced under the brand name Cetavlon. It is used as a 1-3 % solution for cleaning roadside accident wounds. ICI also introduced Savlon, which was a combination of cetrimide and chlorhexidine. ICI sold the Savlon brand OTC to Johnson & Johnson in May 1992. Cetrimide is used in various applications such as antiseptic agents, diagnostic test and analysis, topical formulations, and dental treatment. — Wikipedia

Clinical trial activity

1 trials · 3 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Jan 15, 2019 (NCT03865147)

Timeline

2010s

  1. Jan 1, 2019

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetSurfactant

    surfactant

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT03865147Phase 2Jan 15, 2019Medical Ethics UK Ltd, ProTherax Ltd, Welsh Wound Innovation Centre Ltd
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (3)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Medical Ethics UK LtdFor profit1112019
ProTherax LtdFor profit1012019
Welsh Wound Innovation Centre LtdAcademic/Hospital1012019
3 organizations
Page 1 / 1